Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Makoto Chuma
Successful Treatment With Sorafenib for Sunitinib-Refractory Metastatic Papillary Renal Cell Carcinoma: Potential Impact of Raf Overexpression on Predicting the Efficacy of Sorafenib
IJU Case Reports
Related publications
Phase II Study of Sorafenib in Patients With Sunitinib-Refractory Metastatic Renal Cell Cancer
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Efficacy of Cryoablation Combined With Sorafenib for the Treatment of Advanced Renal Cell Carcinoma
International Journal of Hyperthermia
Medicine
Cancer Research
Radiological
Physiology
Ultrasound Technology
Sorafenib With Interleukin-2 vs Sorafenib Alone in Metastatic Renal Cell Carcinoma: The ROSORC Trial
British Journal of Cancer
Cancer Research
Oncology
Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma
Therapeutic Advances in Urology
Urology
Pcn165 - Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Critical Appraisal of Sorafenib in the Treatment of Chinese Patients With Renal Cell Carcinoma
OncoTargets and Therapy
Oncology
Pharmacology
Cost-Effectiveness and Cost-Utility Analysis of Sunitinib Versus Sorafenib and Bevacizumab + Interferon-Alfa as First-Line Treatment for Metastatic Renal Cell Carcinoma in Ecuador
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Successful Treatment of Hepatocellular Carcinoma With Regorafenib After Sorafenib-Induced Hypersensitivity
Internal Medicine
Internal Medicine
Medicine
Bevacizumab, Sorafenib Tosylate, Sunitinib and Temsirolimus for Renal Cell Carcinoma: A Systematic Review and Economic Evaluation
Health Technology Assessment
Medicine
Health Policy
